Marqueur des tumeurs YRA385 // YRA391

The Tumor Test Marker YRA385 // YRA391 is an advanced test kit designed for high accuracy and reliability in the detection of various tumor markers. This kit is tailored for use with chemiluminescence immunoassay (CLIA) analyzers and is proficient in identifying 18 distinct tumor markers. Early detection of cancer is pivotal, and this test kit plays a crucial role by detecting elevated tumor marker levels in the blood, which aids in diagnosing and recognizing various malignant tumors, providing timely and essential information for patient care.

Market Price

Understanding the value and cost-effectiveness of medical tools is important for practitioners and institutions alike. The Tumor Test Marker YRA385 // YRA391 is competitively priced, typically ranging from $150 to $250 per kit, depending on the quantity and specific supplier agreements. For an exact quote tailored to your requirements, feel free to request a quotation via our Kalstein Plus platform.

Frequently Asked Questions

Q: What tumor markers are tested using this kit?
A: The kit tests for various markers including AFP, CEA, CA125, CA15-3, CA19-9, f-PSA, and t-PSA.

Q: How should the product be stored?
A: The product should be stored at temperatures between 2-8°C to maintain its efficacy.

Q: What certification does the product have?
A: It is certified with CE, ISO13485, and FSC approvals, ensuring its quality and compliance with international standards.

Advantages and Disadvantages

The Tumor Test Marker YRA385 // YRA391 offers significant advantages, including high specificity and sensitivity, early detection capabilities, and CE certification, ensuring trustworthy results. However, potential disadvantages could include the necessity of specific equipment for analysis and the need for trained personnel to interpret the outcomes correctly.

Product Usage in the Field

In practical settings, this test kit is primarily used in hospitals and research laboratories. It aids oncologists and researchers in monitoring cancer treatment efficacy, identifying recurrence, and providing prognostic evaluations. The kit is used by professionals to accurately measure tumor marker levels, thereby influencing treatment decisions.

Recommendations

To ensure the optimal performance of the Tumor Test Marker YRA385 // YRA391, it is recommended to strictly follow the storage guidelines and regularly calibrate the immunoassay analyzer used with it. Operators should undergo periodic training to stay updated with best practices in handling and interpreting test results for precise diagnostics.

Features

• Detection of 18 tumor markers
• Compatible with CLIA analyzers
• CE, ISO13485, and FSC certified
• Available in multiple package specifications: 50T/BOX, 100T/BOX, 24T/BOX
• Requires storage at 2-8°C

Technical Specifications